tbuckley/cabot-search huggingface dataset:
Pneumocystis carinii
Authors: William B. Hamlin
Journal: JAMA (1968)

In 300 cases of leukemia and malignant lymphoma, the overall incidence of<i>Pneumocystis carinii</i>infestation was 5% as compared to a 1% incidence in 110 infants and 0% in 245 consecutive autopsies (excluding newborns and patients with leukemia or lymphoma). Gomori's methenamine silver staining is recommended as a routine procedure in the examination of lung tissue in all cases of leukemia and malignant lymphoma. It is suggested that the recognition of<i>Pneumocystis carinii</i>infestation will increase significantly with this technique.
Medical education programs sponsored by government agencies
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Table of Contents
Authors: Klaus Thurau, Detlef Schlöndorff, Jürgen Schnermann, Ben Caplin, Chih-Wei Yang, Shuchi Anand, Adeera Levin, Magdalena Madero, Rajiv Saran, Saroj Jayasinghe, Marc De Broe, Karen Yeates, Marcello Tonelli, Kristina Jakobsson, Luisa Strani, Agnese Ruggiero, Jason Glaser, Ekti Martin, Neil Pearce, Tomoko Takano, Eric Bareke, Naoki Takeda, Lamine Aoudjit, Cindy Baldwin, Philip Pisano, Jun Matsuda, Jasmine Andalousi, Lina Muhtadie, Chantal Bernard, Jacek Majewski, Toru Miyazaki, Ken-Ichi Yamamura, Indra Gupta, Shuangqin Chen, Haiyan Fu, Songzhao Wu, Wenjuan Zhu, Jinlin Liao, Xue Hong, Jinhua Miao, Congwei Luo, Yongping Wang, Fan Hou, Lili Zhou, Youhua Liu, Martin Müller, John Hoppe, Andrei Bideak, Moritz Lux, Maja Lindenmeyer, Susanna Müller, Nuru Eltrich, Bernhard Ryffel, Volker Vielhauer, Matthew Butler, Raina Ramnath, Hiroyuki Kadoya, Dorinne Desposito, Anne Riquier-Brison, Joanne Ferguson, Karen Onions, Anna Ogier, Hesham Elhegni, Richard Coward, Gavin Welsh, Rebecca Foster, Janos Peti-Peterdi, Simon Satchell, Emilia Vigolo, Lajos Markó, Christian Hinze, Dominik Müller, Ruth Schmidt-Ullrich, Kai Schmidt-Ott, Hiroaki Kikuchi, Emi Sasaki, Naohiro Nomura, Takayasu Mori, Yoji Minamishima, Yuki Yoshizaki, Naohiro Takahashi, Taisuke Furusho, Yohei Arai, Shintaro Mandai, Takahiro Yamashita, Fumiaki Ando, Yasuhiro Maejima, Kiyoshi Isobe, Tomokazu Okado, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara, Masayoshi Kukida, Masaki Mogi, Harumi Kan-No, Kana Tsukuda, Hui-Yu Bai, Bao-Shuai Shan, Toshifumi Yamauchi, Akinori Higaki, Li-Juan Min, Jun Iwanami, Takafumi Okura, Jitsuo Higaki, Masatsugu Horiuchi
Journal: Kidney International (2018)
SUBJECT INDEX
Journal: Circulation Research (1970)

Acacia inhibition of reflex vasoconstriction after experimental coronary embolization in dogs, 211 Acetylcholine effects of acetylstrophanthidin on isolated veins, 647 inhibition of coronary vasodilating action by dipyridamole and adenosine by aminophylline, 743 propagated vasodilation, 163 Acetylstrophanthidin effects on isolated veins of dogs, 647 isometric, afterloaded and isotonic contractions, 279 Acid-base changes contractility in isolated mammalian heart muscle after, 269 Aconitine initiation of fibrillation, 201 Action potential aortic bodies in dogs, 235 effect of DPH on atrial membrane potential, 17 effects of MJ 1999 on cardiac tissue, 661 electrophysiological properties of A-V conducting system, 361 pacemaker shifts within sinoatrial region, 339 propagation of impulses across the Purkinje fibermuscle junctions in dog heart, 135 Actomyosin cardiac impairment in adrenal insufficiency, 419 Adenine nucleotides effects of adenosine compounds on renal function and renin secretion, 327 Adenosine effects of compounds on renal function and renin secretion in dogs, 327 inhibition of coronary vasodilating action by dipyridamole and adenosine by aminophylline, 743 nucleosides in coronary occlusion, 301 Adenosine 3', 5'-monophosphate.See Cyclic AMP Adenyl cyclase positive inotropic effects of dibutyryl cyclic AMP, 35 Adipose tissue blood flow, oxygen consumption, and free fatty acid release in subcutaneous adipose tissue during hemorrhagic shock, 733 Adrenal insufficiency cardiac myosin in, 421 Adrenalectomy adrenergic mechanisms in effects of histamine in pulmonary circulation, 379 Adrenergic blocking action effects of MJ 1999 on cardiac tissue, 661 Adrenergic fibers dual adrenergic and cholinergic innervation of cerebral arteries in rats, 635 Adrenergic mechanisms in effects of histamine in pulmonary circulation, 379 Afferent constriction effects of adenosine compounds on renal function and renin secretion, 327
La fisiopatologia clinica e sperimentale della lipemia.
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Birth Injuries of the Central Nervous System. Part I—Cerebral Birth Injuries.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma
Authors: N Ogata
Journal: Hepatology (1991)

Somatic alterations of the c-Ha-ras gene were examined in 21 Japanese patients with hepatocellular carcinoma. Restriction endonuclease analysis by double digestion with MspI and HpaII revealed that DNAs from two of 21 hepatocellular carcinoma tissues were affected by nucleotide substitution at the twelfth amino acid coding sequence of the c-Ha-ras gene. DNAs from cirrhotic noncancerous liver tissue, but not leukocytes, of one of these patients possessed the mutation, whereas DNAs from noncirrhotic liver tissue and leukocytes of the other patient did not. In one of the nine patients harboring heterozygosity for c-Ha-ras—related BamHI-fragments, the loss of one allele was demonstrated as a somatic change not only in DNA from the tumor tissue but also in DNA from the cirrhotic nontumorous tissue. In two of the 19 patients comparatively examined for digestion patterns of c-Ha-ras locus with HpaII and MspI, extensive methylation was observed as a somatic modification in both DNAs from the tumor and the cirrhotic nontumorous tissues. These results thus indicate that the genetic lesions affecting the c-Ha-ras gene do occur in human hepatocellular carcinoma and probably serve as one of the multiple steps in the process of hepatic carcinogenesis. (HEPATOLOGY 1991; 13:31–37).
SECRETARY TAFT AND THE ARMY MEDICAL DEPARTMENT.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Contents
Authors: J Schrader, ? Haedrich, J.-F Dufour, B Langhans, B Kupfer, I Braunschweiger, S Arndt, W Schulte, H Nischalke, J Nattermann, J Oldenburg, T Sauerbruch, U Spengler, T.-M Scherzer, H Hofer, A Staettermayer, K Rutter, S Beinhardt, P Steindl-Munda, H Kerschner, H Kessler, P Ferenci, E Ohara, N Hiraga, M Imamura, E Iwao, N Kamiya, I Yamada, T Kono, M Onishi, D Hirata, F Mitsui, T Kawaoka, M Tsuge, S Takahashi, H Abe, C Hayes, H Ochi, C Tateno, K Yoshizato, S Tanaka, K Chayama, H.-H Walter, J Thein, H Amin, K Gidding, M Ward, J Law, G George, J Lange, E Bojunga, M Ramos-Lopez, A Von Wagner, J Hassler, E Vermehren, K Herrmann, S Badenhoop, C Zeuzem, Cirrhosis Pradella, S Bonetto, S Turchetto, L Uxa, C Comar, F Zorat, V De Angelis, G Pozzato
Journal: Journal of Hepatology (2011)
Bicycle spoke injuries.
Journal: BMJ (1969)

NITALJOHRNALhearing acuity nonfunctional for purposes of communication."The late onset and progressive nature of this form of deafness are truly forbidding.There is no possibility of averting hearing loss by stopping treatment at the first sign of damage.It must be assumed that the greater part of the antibiotic in each instillation was absorbed, as indeed might be expected, since there is little difference in principle between the irrigation of a well-sealed cavity and simple parenteral injection.Hence, if local treatment is adopted, the daily amount should be limited to that considered safe by injection -certainly not more then 1 g.-and it would be wise to continue the treatment for not more than seven days.The same considerations should apply to all forms of local applica- tion, including the treatment of skin infections and burns and instillations into serous and other cavities.7
Alcoholics eponymous
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
Authors: Peiwei Huangyang, Fuming Li, Pearl Lee, Itzhak Nissim, Aalim M. Weljie, Anthony Mancuso, Bo Li, Brian Keith, Sam S. Yoon, M. Celeste Simon
Journal: Cell Metabolism (2020)
Quality-of-Life–Adjusted Survival Analysis of High-Dose Adjuvant Interferon Alfa-2b for High-Risk Melanoma Patients Using Intergroup Clinical Trial Data
Authors: Kerry L. Kilbridge, Bernard F. Cole, John M. Kirkwood, Frank G. Haluska, Michael A. Atkins, John C. Ruckdeschel, Dana E. Sock, Robert F. Nease, Jane C. Weeks
Journal: Journal of Clinical Oncology (2002)

PURPOSE: High-dose adjuvant interferon alfa-2b (IFNα2b) for high-risk melanoma is a 1-year regimen that improves relapse-free and overall survival but has significant toxicity. A quality-of-life–adjusted survival (QAS) analysis analysis of two cooperative group phase III trials, E1684 and E1690/S9111/C9190, was performed, incorporating patient values (utilities) for the toxicity of IFNα2b treatment and melanoma recurrence. PATIENTS AND METHODS: Quality-Adjusted Time Without Symptoms or Toxicity methodology was used with melanoma patient utilities and trial data to estimate the effect of IFNα2b on QAS. The increase or decrease in QAS that patients could expect from treatment was estimated based on their utilities. Eleven utility predictor questions were tested to identify patients with utilities that result in decreased QAS. RESULTS: Using E1684 data, IFNα2b would result in an increase in QAS for all sets of patient utilities. This benefit was significant (P &lt; .05) for 16% of patients. Using E1690/S9111/C9190 data, 77% of patients would experience a benefit in QAS from IFNα2b and 23% would experience a decrease in QAS; neither of these effects was statistically significant. Using utility predictors and the E1690/S9111/C9190 analysis, a decision rule was formulated that helps identify patients in whom IFNα2b may detract from QAS. CONCLUSION: Most patients experienced improvement in QAS in both trials, but this benefit was statistically significant in only 16% of patients in E1684. Change in QAS depends more on the utility for IFNα2b toxicity than on the utility for melanoma recurrence. Cancer patients probably have higher utilities for IFNα2b toxicity than members of the general population and will tend to favor IFNα2b treatment as a result.
Miscellany
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Selective vision
Authors: Marc H. Bornstein
Journal: Behavioral and Brain Sciences (1997)

The physics of color and the psychology of color naming are not isomorphic. Physically, the spectrum is continuous with regard to wavelength – one point in the spectrum differs from another only by the amount of wavelength difference. Psychologically, hue is categorical – colors change qualitatively from one wavelength region to another. The psychological characterization of hue that characterizes color vision has been revealed in a series of modern psychophysical studies with human adults and infants and with various infrahuman species, including vertebrates and invertebrates. These biopsychological data supplant an older psycholinguistic and anthropological literature that posited that language and culture alone influence perceptual processes; language and culture may modify color naming beyond basic categorizations.
Die Klinik der Tuberkulose Erwachsener.
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Task Force 1: The ACCF and AHA Codes of Conduct in Human Subjects Research
Authors: Joseph S. Alpert, Kenneth I. Shine, Robert J. Adams, Elliott M. Antman, Rae Ellen W. Kavey, Lawrence Friedman, Robert L. Frye, Robert A. Harrington, David Korn, Jon F. Merz, Elizabeth Ofili
Journal: Circulation (2004)
AMA Insights
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Poison Ivy.
Authors: A. L. Benedict
Journal: JAMA (1906)

Buffalo, N. Y., March 17, 1906. <h3>To the Editor:</h3> —Referring to the discussion in regard to<i>Rhus toxicodendron and Rhus venenata</i>in your issues of January 27 and March 17, and intervening issues, I would like to make some observations and to ask some questions. I seem to be immune. When a little boy, spending the summer vacations on a farm, I repeatedly tried to poison myself by walking through patches of ivy barefoot, and even rubbing it into the skin and into abraded places, but failed in a number of trials in several summers. My object was to exchange the hygienic advantages and loneliness of the country for the more familiar disadvantages of the city. For a number of years afterward I did not hesitate to handle the plant freely, and was never poisoned. Since arriving at years of relative discretion I have avoided the plant as a matter